vs
AMERICAN WOODMARK CORP（AMWD）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是AMERICAN WOODMARK CORP的2.0倍（$772.1M vs $394.6M），Revvity净利率更高（12.7% vs 1.5%，领先11.2%），Revvity同比增速更快（5.9% vs -12.8%），Revvity自由现金流更多（$161.8M vs $638.0K），过去两年Revvity的营收复合增速更高（9.0% vs -3.3%）
美国木标公司是一家厨卫橱柜制造商，总部位于弗吉尼亚州温彻斯特。公司在美国多地设有多家生产基地与服务中心，其中生产基地分布在亚利桑那州、佐治亚州、印第安纳州、肯塔基州、马里兰州、田纳西州、弗吉尼亚州以及西弗吉尼亚州，服务网点覆盖全美各地。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
AMWD vs RVTY — 直观对比
营收规模更大
RVTY
是对方的2.0倍
$394.6M
营收增速更快
RVTY
高出18.6%
-12.8%
净利率更高
RVTY
高出11.2%
1.5%
自由现金流更多
RVTY
多$161.2M
$638.0K
两年增速更快
RVTY
近两年复合增速
-3.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $394.6M | $772.1M |
| 净利润 | $6.1M | $98.4M |
| 毛利率 | 15.2% | — |
| 营业利润率 | 3.1% | 14.5% |
| 净利率 | 1.5% | 12.7% |
| 营收同比 | -12.8% | 5.9% |
| 净利润同比 | -78.0% | 3.9% |
| 每股收益（稀释后） | $0.42 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMWDRVTY
| Q4 25 | $394.6M | $772.1M | ||
| Q3 25 | $403.0M | $698.9M | ||
| Q2 25 | $400.4M | $720.3M | ||
| Q1 25 | $397.6M | $664.8M | ||
| Q4 24 | $452.5M | $729.4M | ||
| Q3 24 | $459.1M | $684.0M | ||
| Q2 24 | $453.3M | $691.7M | ||
| Q1 24 | $422.1M | $649.9M |
净利润AMWDRVTY
| Q4 25 | $6.1M | $98.4M | ||
| Q3 25 | $14.6M | $46.7M | ||
| Q2 25 | $25.6M | $53.9M | ||
| Q1 25 | $16.6M | $42.2M | ||
| Q4 24 | $27.7M | $94.6M | ||
| Q3 24 | $29.6M | $94.4M | ||
| Q2 24 | $26.8M | $55.4M | ||
| Q1 24 | $21.2M | $26.0M |
毛利率AMWDRVTY
| Q4 25 | 15.2% | — | ||
| Q3 25 | 16.7% | 53.6% | ||
| Q2 25 | 17.0% | 54.5% | ||
| Q1 25 | 15.0% | 56.5% | ||
| Q4 24 | 18.9% | — | ||
| Q3 24 | 20.2% | 56.3% | ||
| Q2 24 | 18.6% | 55.7% | ||
| Q1 24 | 19.2% | 54.6% |
营业利润率AMWDRVTY
| Q4 25 | 3.1% | 14.5% | ||
| Q3 25 | 5.0% | 11.7% | ||
| Q2 25 | 7.4% | 12.6% | ||
| Q1 25 | 5.3% | 10.9% | ||
| Q4 24 | 9.4% | 16.3% | ||
| Q3 24 | 10.2% | 14.3% | ||
| Q2 24 | 8.4% | 12.4% | ||
| Q1 24 | 6.6% | 6.8% |
净利率AMWDRVTY
| Q4 25 | 1.5% | 12.7% | ||
| Q3 25 | 3.6% | 6.7% | ||
| Q2 25 | 6.4% | 7.5% | ||
| Q1 25 | 4.2% | 6.4% | ||
| Q4 24 | 6.1% | 13.0% | ||
| Q3 24 | 6.5% | 13.8% | ||
| Q2 24 | 5.9% | 8.0% | ||
| Q1 24 | 5.0% | 4.0% |
每股收益（稀释后）AMWDRVTY
| Q4 25 | $0.42 | $0.86 | ||
| Q3 25 | $1.00 | $0.40 | ||
| Q2 25 | $1.73 | $0.46 | ||
| Q1 25 | $1.09 | $0.35 | ||
| Q4 24 | $1.79 | $0.77 | ||
| Q3 24 | $1.89 | $0.77 | ||
| Q2 24 | $1.70 | $0.45 | ||
| Q1 24 | $1.32 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.1M | $919.9M |
| 总债务越低越好 | $363.3M | — |
| 股东权益账面价值 | $928.2M | $7.3B |
| 总资产 | $1.6B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.39× | — |
8季度趋势，按日历期对齐
现金及短期投资AMWDRVTY
| Q4 25 | $52.1M | $919.9M | ||
| Q3 25 | $54.9M | $931.4M | ||
| Q2 25 | $48.2M | $991.8M | ||
| Q1 25 | $43.5M | $1.1B | ||
| Q4 24 | $56.7M | $1.2B | ||
| Q3 24 | $89.3M | $1.2B | ||
| Q2 24 | $87.4M | $2.0B | ||
| Q1 24 | $97.8M | $1.7B |
总债务AMWDRVTY
| Q4 25 | $363.3M | — | ||
| Q3 25 | $364.8M | — | ||
| Q2 25 | $365.8M | — | ||
| Q1 25 | $367.3M | — | ||
| Q4 24 | $368.0M | — | ||
| Q3 24 | $372.2M | — | ||
| Q2 24 | $371.8M | — | ||
| Q1 24 | $371.3M | — |
股东权益AMWDRVTY
| Q4 25 | $928.2M | $7.3B | ||
| Q3 25 | $920.3M | $7.4B | ||
| Q2 25 | $916.0M | $7.6B | ||
| Q1 25 | $919.6M | $7.6B | ||
| Q4 24 | $915.1M | $7.7B | ||
| Q3 24 | $913.8M | $7.9B | ||
| Q2 24 | $910.4M | $7.9B | ||
| Q1 24 | $896.9M | $7.8B |
总资产AMWDRVTY
| Q4 25 | $1.6B | $12.2B | ||
| Q3 25 | $1.6B | $12.1B | ||
| Q2 25 | $1.6B | $12.4B | ||
| Q1 25 | $1.6B | $12.4B | ||
| Q4 24 | $1.6B | $12.4B | ||
| Q3 24 | $1.6B | $12.8B | ||
| Q2 24 | $1.6B | $13.4B | ||
| Q1 24 | $1.6B | $13.4B |
负债/权益比AMWDRVTY
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $638.0K | $161.8M |
| 自由现金流率自由现金流/营收 | 0.2% | 21.0% |
| 资本支出强度资本支出/营收 | 2.7% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.83× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $64.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流AMWDRVTY
| Q4 25 | $11.2M | $182.0M | ||
| Q3 25 | $33.1M | $138.5M | ||
| Q2 25 | $44.8M | $134.3M | ||
| Q1 25 | $11.0M | $128.2M | ||
| Q4 24 | $11.9M | $174.2M | ||
| Q3 24 | $40.8M | $147.9M | ||
| Q2 24 | $43.3M | $158.6M | ||
| Q1 24 | $43.7M | $147.6M |
自由现金流AMWDRVTY
| Q4 25 | $638.0K | $161.8M | ||
| Q3 25 | $25.3M | $120.0M | ||
| Q2 25 | $35.8M | $115.5M | ||
| Q1 25 | $2.3M | $112.2M | ||
| Q4 24 | $1.1M | $149.8M | ||
| Q3 24 | $29.5M | $125.6M | ||
| Q2 24 | $7.2M | $136.6M | ||
| Q1 24 | $22.1M | $129.7M |
自由现金流率AMWDRVTY
| Q4 25 | 0.2% | 21.0% | ||
| Q3 25 | 6.3% | 17.2% | ||
| Q2 25 | 8.9% | 16.0% | ||
| Q1 25 | 0.6% | 16.9% | ||
| Q4 24 | 0.2% | 20.5% | ||
| Q3 24 | 6.4% | 18.4% | ||
| Q2 24 | 1.6% | 19.7% | ||
| Q1 24 | 5.2% | 20.0% |
资本支出强度AMWDRVTY
| Q4 25 | 2.7% | 2.6% | ||
| Q3 25 | 1.9% | 2.6% | ||
| Q2 25 | 2.2% | 2.6% | ||
| Q1 25 | 2.2% | 2.4% | ||
| Q4 24 | 2.4% | 3.4% | ||
| Q3 24 | 2.5% | 3.3% | ||
| Q2 24 | 8.0% | 3.2% | ||
| Q1 24 | 5.1% | 2.7% |
现金转化率AMWDRVTY
| Q4 25 | 1.83× | 1.85× | ||
| Q3 25 | 2.27× | 2.97× | ||
| Q2 25 | 1.75× | 2.49× | ||
| Q1 25 | 0.66× | 3.03× | ||
| Q4 24 | 0.43× | 1.84× | ||
| Q3 24 | 1.38× | 1.57× | ||
| Q2 24 | 1.62× | 2.87× | ||
| Q1 24 | 2.06× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMWD
| Home Center Retailers | $166.7M | 42% |
| Builders | $164.7M | 42% |
| Independent Dealersand Distributors | $63.2M | 16% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
